Alnylam Pharmaceuticals, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 8731 https://www.alnylam.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

Alnylam (ALNY) Posts Strong Preliminary Revenues for 4Q & FY22 - Jan 9th, 2023 6:22 pm
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2022 Global Net Product Revenues and Provides Additional Updates - Jan 8th, 2023 11:00 pm
3 Growth Stocks That Could Rocket Higher in 2023 - Jan 6th, 2023 10:39 am
Alnylam Announces Updates to its Board of Directors - Jan 5th, 2023 9:00 pm
VERA Dips Despite Positive Data From IgA Nephropathy Study - Jan 4th, 2023 5:20 pm
Alnylam to Webcast Presentation at 41st Annual J.P. Morgan Healthcare Conference - Jan 3rd, 2023 9:00 pm
The Petri Dish: Third Harmonic axes lead program; bluebird moves forward with 3rd drug - Dec 22nd, 2022 10:41 am
Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes - Dec 21st, 2022 1:00 pm
Alnylam Announces 2023 Product and Pipeline Goals and Provides Program Updates at R&D Day - Dec 15th, 2022 1:00 pm
Is There An Opportunity With Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 44% Undervaluation? - Dec 13th, 2022 1:29 pm
Clovis (CLVS) Down 18.1% Since Last Earnings Report: Can It Rebound? - Dec 9th, 2022 4:30 pm
Alnylam (ALNY) Seeks to Expand Onpattro Label in Cardiomyopathy - Dec 9th, 2022 4:21 pm
Alnylam Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration (FDA) for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis - Dec 8th, 2022 9:00 pm
Alnylam to Webcast Virtual R&D Day - Dec 8th, 2022 12:00 pm
Why Is Intercept (ICPT) Down 3.9% Since Last Earnings Report? - Dec 1st, 2022 4:31 pm
Alnylam Ranks #1 on Boston Globe’s Top Places to Work List for 2022 - Dec 1st, 2022 12:00 pm
Alnylam to Webcast Presentations at Upcoming November Investor Conferences - Nov 9th, 2022 1:00 pm
Investors ignore increasing losses at Alnylam Pharmaceuticals (NASDAQ:ALNY) as stock jumps 7.3% this past week - Nov 2nd, 2022 3:45 pm
Top 10 Stock Picks of Eli Casdin’s Casdin Capital - Oct 31st, 2022 12:49 pm
Alnylam Recognized by Science Magazine as Top Employer for Fourth Consecutive Year - Oct 27th, 2022 6:00 pm